Markus Warmuth
President & CEO at Monte Rosa Therapeutics. Based in Boston, Massachusetts.
- Rank
- 14022nd of 14,644
- Companies held
- 1
- Largest holding
- GLUE, 100.0% of total
- Latest SEC filing
- Jul 16, 2026
What the $5.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics GLUE Common Stock | Directly | 585,038 | $8.95 | $5.2M | 100.0% | Form 4, Jul 16, 2026 |
Share counts are the amounts Markus Warmuth reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Sold | GLUE | 9,500 | $23.18 | $220K | View |
| Jun 1, 2026 | Sold | GLUE | 4,998 | $19.41 | $97K | View |
| Jun 1, 2026 | Sold | GLUE | 468 | $19.73 | $9K | View |
| May 1, 2026 | Sold | GLUE | 5,467 | $18.92 | $103K | View |
| Apr 14, 2026 | Sold | GLUE | 8,000 | $17.64 | $141K | View |
| Mar 2, 2026 | Sold | GLUE | 5,466 | $17.92 | $98K | View |
| Jan 7, 2026 | Sold | GLUE | 309 | $24.57 | $8K | View |
| Jan 7, 2026 | Sold | GLUE | 1,450 | $23.88 | $35K | View |
| Jan 7, 2026 | Sold | GLUE | 3,707 | $23.24 | $86K | View |
| Jan 5, 2026 | Sold | GLUE | 10,135 | $15.17 | $154K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 14019 | Jason A. Kary SVP, Keysight Technologies. Santa Rosa, CA | $5.2M |
| 14020 | James Lance Carter President and CEO, HBT Financial. Bloomington, IL | $5.2M |
| 14021 | Paul C. Woelkers Director, Fidelity D & D Bancorp. Moscow, PA | $5.2M |
| 14022 | Markus Warmuth President & CEO, Monte Rosa Therapeutics. Boston, MA | $5.2M |
| 14023 | Soon Huat Lim Chief Executive Officer, Trident Digital Tech Holdings | $5.2M |
| 14024 | Peter Leddy See Remarks, Maravai LifeSciences Holdings. San Diego, CA | $5.2M |
| 14025 | Matthew McGrew Executive Vice President, Danaher. Washington, DC | $5.2M |
Questions
How much stock does Markus Warmuth own?
Markus Warmuth holds $5,236,090 in listed stock based on SEC filings and current prices, mostly Monte Rosa Therapeutics (GLUE). That ranks 14022nd on the Stock Rich List.
Is this Markus Warmuth's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Markus Warmuth last buy or sell stock?
The most recent open-market trade on file is a sale of 9,500 GLUE shares on Jul 16, 2026 at $23.18.